Semiconducting polymer (SP)-based afterglow luminogens are showing increasing potential for in vivo imaging because of their long-life luminescence and the associated benefits (e.g., zeroautofluorescence background and high signal-to-noise ratio). However, such organic afterglow luminescence agents are still rare and their application is usually limited by their relatively low afterglow intensity and short afterglow duration. Herein, we report an aggregation-induced emission (AIE) dyepowered SP afterglow luminogen by leveraging on the unique characteristics of an AIE dye to circumvent the concentration-quenching effect, enhance afterglow intensity and prolong afterglow duration. The underlying working mechanism is investigated by a series of experiments and it is found that the AIE dye provides sufficient 1 O 2 to excite SPs and form massive amounts of high-energy intermediates, and then the SP intermediates emit photons that can activate the AIE dye to generate 1 O 2 and simultaneously trigger the energy transfer process between the SPs and AIE dye, resulting in a deepred emission. It is this closed-loop of "photon-1 O 2 -SP intermediates-photon" that provides the afterglow emission even after the cessation of the excitation light. The as-prepared luminogen shows good performance in in vivo tumour imaging. This study demonstrates the advantages of AIE-facilitated afterglow luminescence and discloses its mechanism, and hopefully it could inspire the development of other innovative designs for cancer theranostics.
Introduction
Aerglow is a sustained self-luminescence process aer the cessation of external light excitation. 1, 2 Thanks to its zero-autouorescence background, aerglow imaging can provide high signal-to-noise ratio images and thus it is attracting increasing attention in the elds of biosensing, bioimaging and imaging-guided surgery or therapy. [3] [4] [5] [6] Nevertheless, this advanced imaging technique suffers from a severe shortage of high-quality aerglow materials. [7] [8] [9] [10] To date, only two kinds of aerglow materials have been reported for aerglow imaging applications, which are rareearth heavy metal ion (e.g., europium, dysprosium and praseodymium) doped inorganic nanoparticles and SP-based organic aerglow nanoparticles. 11, 12 The luminescence mechanism of inorganic aerglow materials can be described as a physical process of de-trapping stored photo energy in intrinsic defects in the form of photonic emission. 13, 14 It is clear from the literature that inorganic aerglow materials are usually synthesized via an annealing reaction method at high temperatures (>800 C), showing good luminance performance but easily resulting in agglomeration and particularly biosafety concerns (heavy metal toxicity, poor biodegradability and difficulty of surface modication). [15] [16] [17] [18] In contrast, organic aerglow materials are considered to be superior to inorganic aerglow materials in terms of biocompatibility, biodegradability and surface functionalization, which are conducive to bioimaging applications. [19] [20] [21] [22] However, compared with inorganic aerglow materials, organic aerglow ones are relatively underdeveloped. Recently, Pu et al. reported a category of semiconducting polymers (SPs), namely poly[2-methoxy-5-(2ethylhexyloxy)-1,4-phenylenevinylene] (MEHPPV) and its analogues, showing effective aerglow photons aer removal of external light irradiation. 23, 24 Different from the inorganic aerglow mechanism, the SP-based aerglow is more like a light-induced chemiluminescence which has been demonstrated by Pu et al. as follows: the vinyl bonds (C]C) of MEHPPV are oxidized by 1 O 2 under light excitation to yield unstable intermediates (1,2-dioxetane), followed by a radiative relaxation of the excited species from degraded intermediates to their ground state accompanied by light emission. 23, 25, 26 Unfortunately, these SPs have poor performance in aerglow emission. Selection of a suitable SP is of great importance to aerglow imaging. Compared with other reported SPs (such as MEHPPV and its analogues), poly [(9,9- di(2-ethylhexyl)-9H-uorene-2,7-vinylene)-co-(1-methoxy-4-(2-ethylhexyloxy)-2,5phenylenevinylene)] (PFPV) is considered better as an aerglow substrate since its highest occupied molecular orbital (HOMO) is close to the lowest unoccupied molecular orbital (LUMO) of dioxetane intermediates, and thus the intermolecular electron transfer between them can be facilitated, improving the quantum yield. 27, 28 However, the light-induced 1 O 2 generation of PFPV is relatively low which results in unsatisfactory aerglow intensity and duration, and the short emission wavelength (<600 nm) hinders its in vivo imaging applications. 29, 30 Therefore, increasing the amount of 1 O 2 generation and red-shiing of the emission are urgently needed for bioimaging.
Just recently, Pu and others developed strategies to amplify and red-shi the aerglow emission by doping photosensitizers to enhance 1 O 2 generation and optimize the emission pattern. [31] [32] [33] [34] Although a number of exciting results have been obtained, most of the photosensitizer molecules suffer from aggregation-caused quenching (ACQ) side-effects, resulting in limited enhancements in luminescence intensity and 1 O 2 generation. 23, 29 Yet, aggregation-induced emission (AIE) dyes with anti-ACQ characteristics provide an opportunity to circumvent the concentration-quenching effect, achieving high emission brightness in the aggregated state. [35] [36] [37] [38] [39] Moreover, it has been reported that AIE dyes can also efficiently generate 1 O 2 under irradiation. [40] [41] [42] [43] [44] To our knowledge, there are few reports on AIE dye-facilitated aerglow materials and particularly the study on their working mechanism is severely lacking. What is more, the study of these aerglow nanomaterials for in vivo tumour imaging via intravenous injection in animal models is somehow rather scarce. [45] [46] [47] It should be noted that intravenous injection is one of the most important administration routes in clinics.
In this study, we are thus motivated to develop a novel aerglow luminogen to address the above mentioned issues for in vivo tumor imaging. To achieve this purpose, the reported PFPV was used as a light-induced aerglow matrix, and 2-((5-(4-(diphenylamino)phenyl)thiophen-2-yl)methylene)malononitrile (TTMN) was synthesized as a photosensitizer with AIE characteristics and efficient 1 O 2 generation ability to power the aerglow emission of PFPV. These two functional chemicals were conned in a homogeneous nanostructure (P-TNPs) by an amphiphilic triblock copolymer (F127), allowing an efficient energy transfer process for aerglow emission. PFPV was selected because of its reported stronger luminescence intensity than other SPs and TTMN was selected because its absorption window (400 nm-600 nm) signicantly overlaps with the emission of PFPV (500 nm-700 nm) which is of great importance to facilitating resonance energy transfer. Aer the cessation of white LED irradiation (Scheme 1), the aerglow emitted from the decomposition of PFPV-dioxetane intermediates continuously excites TTMN to generate 1 O 2 and red-shis the aerglow wavelength, in turn, the delayed 1 O 2 continuously oxidizes PFPV and therefore forms PFPV-dioxetane intermediates for self-circulating aerglow. This working mechanism was experimentally investigated and conrmed by a series of means. By integrating with an AIE dye, the as-prepared P-TNPs were found to have stronger aerglow emission and longer luminescence time than PFPV. Finally, we demonstrated the superior performance of P-TNPs for aerglow imaging on tumourbearing mice via intravenous injection.
Results and discussion

Synthesis and characterization of P-TNPs
In this work, we synthesized a high 1 O 2 generation AIE dye (TTMN) according to Wang's work, with the aim of powering the PFPV for aerglow emission. 48, 49 Aer purication by silica-gel column chromatography, the structure and the purity of TTMN were identied by 1 H nuclear magnetic resonance ( 1 H NMR) and a liquid chromatograph-mass spectrometer (LC-MS), which are shown in Fig. S1 and S2. † In order to achieve efficient energy transfer between the PFPV and the AIE dye (TTMN), a nanoprecipitation method was used to co-encapsulate PFPV and TTMN into a conned nanostructure with a commercially available amphiphilic triblock copolymer F127 (PEG-b-PPG-b-PEG) which has good water solubility and biocompatibility. 50, 51 In order to obtain a high content of the PFPV matrix and also a stable enough solution, the loading capability of PFPV in F127 (namely the PNP formation capability) was rst investigated. It is found that the aerglow brightness and duration of PNPs increase with the loading content of PFPV in the range of 10 mg mL À1 -150 mg mL À1 (in these cases, no TTMM was used) ( Fig. S3a †) . However, the solution becomes turbid (Fig. S3b †) and the particles seem to aggregate ( Fig. S3c †) when the loading content of PFPV is 150 mg mL À1 . Therefore, 100 mg mL À1 of PFPV was selected for subsequent studies.
Aer PFPV and TTMN were co-encapsulated by F127, namely P-TNPs, the main physiochemical properties were investigated. Dynamic light scattering (DLS) measurements indicate that P-TNPs have an average hydrodynamic diameter of 120 nm ( Fig. 1a ), which is slightly larger than that measured by transmission electron microscopy (TEM) ( Fig. 1b ) due to the shrinkage effect during TEM sample observation. The TEM result reveals that P-TNPs have a uniform spherical morphology. And particularly the contrast of every single particle indicates a homogeneous loading. Zeta potential measurements show a negatively charged surface of P-TNPs with a value of À14.5 mV ( Fig. 1c ), favouring the dispersion of P-TNPs in solution. To verify the co-encapsulation of PFPV and TTMN in P-TNPs, UV-vis and uorescence spectra of PFPV nanoparticles (PNPs) and TTMN nanoparticles (TNPs) and P-TNPs were, respectively, recorded and are shown in Fig. 1d and e. The maximum absorption of TNPs is located at about 500 nm. Aer co-encapsulating TTMN, a 10 nm-redshi was found in the UV-vis absorption spectrum of P-TNPs. This change is not very big because the main composition of P-TNPs is the semiconducting polymer and not the TTMN. For better illustrating this difference, we used dotted lines to label the maximum absorption in Fig. 1d . This absorption pattern change suggests successful incorporation of PFPV and TTMN into a whole nanoparticle. Similarly, the uorescence measurements further verify this co-encapsulation. It should be worth noting that by doping with the AIE dye, a signicant red-shi of the emission of PFPV was achieved, thanks to the efficient uorescence resonance energy transfer (FRET) from the PFPV component to the AIE dye TTMN. Fig. 1f shows an overlap of the absorption of TNPs (400 nm-600 nm) and the emission of PNPs (500 nm-700 nm), which explains the FRET process in the P-TNPs. Moreover, no obvious size alteration or UV-vis absorption changes of P-TNPs were observed aer storage ( Fig. 1g and h), and the digital photographs in Fig. 1i show no macroscopic aggregation aer storage in DMEM and 10% FBS solutions for 7 days, suggesting the excellent stability of P-TNPs under physiological conditions.
Aerglow property studies of P-TNPs
Above we optimized the loading content of PFPV which acts as the aerglow matrix. We further investigated the doping content of TTMN which acts as the aerglow enhancer. For comparison, different doping contents of TTMN were selected from 0% to 20% (w/w) with the same PFPV concentration (0.1 mg mL À1 ) for preparation of P-TNPs. As shown in Fig. 2a , aer exposure to white LED lamp (2000 lm) irradiation for 1 min, AIE dye-doped P-TNPs emit much stronger aerglow luminescence even at a low AIE concentration (5%), compared with AIE free P-TNPs (0% sample) and the pure H 2 O as a control. To be specic, by increasing the doping content of TTMN, the aerglow intensity and the emission duration of P-TNPS (5%, 10%, 15% and 20%) signicantly increase and reach their maximum at the content value of 10% ( Fig. 2b) . Different from the previous reports, 23,29 the saturated aerglow intensity of P-TNPs (10% sample) doesn't present a sharp decrease when the doping content further increases to higher values even at 20% doping amount. This extraordinary aerglow emission should be mainly attributed to the unique features of the AIE effect. To explain this phenomenon more intuitively, a typical ACQ photosensitizer chlorin e6 (Ce6) was used to prepare PFPV-based aerglow nanoparticles (P-Ce6NPs) with the same molar mass of TTMN. As shown in Fig. 2c , the aerglow intensity of P-TNPs is 1.75 times that of P-Ce6NPs. The improved doping content of AIE dyes can signicantly enhance 1 O 2 generation and photon emission, facilitating aerglow emission. As for the slight decrease of aerglow intensity in the other two samples with the doping contents of 15% and 20%, it could be associated with the insufficient energy supply of the matrix of the PFPV component. Therefore, we selected 10% as the doping content of TTMN in P-TNPs.
The aerglow intensity and duration of P-TNPs over time were recorded. As shown in Fig. 2d , neither TNPs nor H 2 O exhibits aerglow signals aer light excitation. Compared with PNPs (without AIE doping) whose aerglow signal almost disappears 0.5 hours aer the cessation of excitation, P-TNPs can emit persistent luminescence at least for 1 hour. Particularly, the aerglow intensity of P-TNPs is much higher than that of PNPs. In order to differentiate the providers of the emitted photons, we used a 630 nm lter to further record the aerglow signals. The calculated results in Fig. S4a † indicate that the aerglow intensity of P-TNPs is 2.02-fold that of PNPs aer ltration, conrming the occurrence of FRET from PFPV to TTMN. These data collectively indicate that doping TTMN is able to efficiently red-shi the emission of PFPV to the red region and also enhance the aerglow intensity. Another important property of P-TNPs in our work is the re-excitability; as shown in Fig. 2e , the aerglow intensity of P-TNPs still remains above half the initial intensity even aer the 4th reexcitation, indicating their capability for longitudinal imaging if necessary. It should be noted that this recharging aerglow performance is not as good as that of inorganic aerglow materials, mainly due to the different aerglow mechanism.
Aerglow mechanism studies of P-TNPs It is reported that the vinyl bonds of SPs can be oxidized by several ROS (e.g., 1 O 2 , H 2 O 2 and ClO À ) for chemiluminescence or aerglow imaging, 23, [27] [28] [29] 52, 53 which is also evaluated in this study and the result is shown in Fig. S4b . † However, there are few systematic studies reported on disclosing this process. The results we obtained above together with published literature point out that the generation of 1 O 2 is a crucial factor for SPbased aerglow luminescence systems.
In this study, 9,10-anthracenediyl-bis(methylene) dimalonic acid (ABDA), 54-56 a typical 1 O 2 indicator, was used to investigate the 1 O 2 generation ability of P-TNPs. It shows that the absorption of ABDA at 375 nm decreases signicantly in the sample of P-TNPs ( Fig. 3a and S5d †), revealing efficient 1 O 2 generation of P-TNPs upon white LED light irradiation (2000 lm), while there is no remarkable decrease in the sample of PNPs or TNPs (Fig. 3a , S5b and c †). On the other hand, a more sensitive 1 O 2 indicator, singlet oxygen sensor green (SOSG), [57] [58] [59] was further applied to test the generation of 1 O 2 by measuring the uorescence intensity of SOSG at 528 nm (SOSG was added before white LED light irradiation). As shown in Fig. 3b and S6, † PNPs and TNPs exhibit slight 1 O 2 generation, but P-TNPs show much higher 1 O 2 generation ability. This result is consistent with the results of ABDA measurements. Interestingly, we noticed that P-TNPs provide more 1 O 2 than TNPs (the pure AIE dye nanoparticles). It can be ascribed to the cumulative effect of 1 O 2 in the sample of P-TNPs. To be specic, in addition to the direct 1 O 2 generation from TTMN upon light irradiation, the energy transfer from the degradation of the formed PFPV-dioxetane intermediates to TTMN further promotes 1 O 2 generation. This portion of 1 O 2 generation is considered delayed since its excitation energy is from the aerglow. And this delayed 1 O 2 in turn accelerates the formation of PFPV-dioxetane intermediates which can be inferred from the absorption decrease rate of PFPV at $450 nm by comparing Fig. S5b and d . †
To prove the delayed 1 O 2 generation in the sample of P-TNPs, a solution of P-TNPs was pre-treated with white LED light irradiation (2000 lm, 2 min), and aer removing the LED lamp, SOSG was added. It can be seen that a prominent increase in the uorescence intensity of SOSG at 528 nm occurs in the P-TNP sample (Fig. 3c ), while no change was observed in the sample of H 2 O, or PNPs, or TNPs (Fig. S7 †) . It should be noted that the life-time of 1 O 2 in water is less than 10 microseconds. Thus, the SOSG uorescence increase in P-TNPs is not caused by the attenuating 1 O 2 but the delayed generation of 1 O 2 in the sample of P-TNPs even aer removing the LED irradiation.
To further disclose the role of 1 O 2 during the interaction between PFPV and TTMN, a classic 1 O 2 quencher 1,4-diazabicyclo[2.2.2]octane (DABCO) was used for study. [60] [61] [62] As shown in Fig. 3d , to the solutions of PNPs and P-TNPs DABCO (250 mM, nal concentration) and an equal volume of H 2 O were pre-added, respectively, and then they were irradiated under a white LED light for 1 min, and nally imaged using an IVIS system with a bioluminescence mode. The aerglow intensities of both the samples of PNPs and P-TNPs with DABCO added decrease sharply and remarkably from the beginning compared with those of the samples with H 2 O added. Particularly, PNPs were found more sensitive to the DABCO quenching, showing rapid aerglow vanishing due to the insufficient 1 O 2 selfgeneration in the sample of PNPs. In contrast, the aerglow intensity of P-TNPs which possess sufficient 1 O 2 supply declines slightly slowly aer light irradiation, further indicating the role of delayed 1 O 2 in enhancing aerglow intensity and duration.
Interestingly, we just adjusted the addition time of DABCO and found different aerglow results. Specically, the DABCO added later was found to show no obvious effect on quenching aerglow emission in the sample of PNPs (Fig. 3e ), while it exerts strong quenching in the sample of P-TNPs. This further conrms the delayed generation of 1 O 2 and its crucial role during the aerglow process of P-TNPs.
Cytotoxicity and 1 O 2 detection at the cellular level
Before in vivo imaging, the cytotoxicity of the as-prepared P-TNPs (concentration range from 50 mg mL À1 to 500 mg mL À1 ) was evaluated on 4T1 cells and DC2.4 cells by standard cell counting kit-8 (CCK-8) assays. As shown in Fig. 4a and b, no obvious cytotoxicity of P-TNPs is observed aer 24 h and 48 h of incubation. The cell viability remains above 75% even at a concentration of 500 mg mL À1 aer incubation for 48 h. We also tested the cytotoxicity of P-TNPs under light irradiation.
Unfortunately, there is no obvious decrease of the 4T1 cell viability rate. The possible reason may be that the generated 1 O 2 was mainly consumed in the aerglow process of P-TNPs.
The generated 1 O 2 level during the aerglow process of P-TNPs at the cellular level was detected with a typical ROS probe 2 0 ,7 0 -dichlorodihydrouorescein diacetate (DCFH-DA). [63] [64] [65] As shown in Fig. 4c , no obvious uorescence is observed in non-treated 4T1 cells (control group) no matter before or aer white LED light irradiation (2000 lm, 3 min). In contrast, enhanced green uorescence signals are observed in the sample of P-TNP-treated cells which indicates that efficient generation of intracellular ROS is induced aer light irradiation, although P-TNPs itself without irradiation can cause weak green uorescence. Red uorescence of P-TNPs excited at 550 nm indicates the successful cell endocytosis of the aerglow materials. PNP and TNP-induced green uorescence intensity of DCF was also, respectively, measured (Fig. S8 †) . It was found that it was hard for PNPs to induce green uorescence. But for TNPs, because of the photodynamic effect of the AIE compound TTMN, they can generate 1 O 2 to induce green uorescence of DCF, which is in accordance with the results of SOSG tests. The quantitative results of green uorescence intensity were calculated by ow cytometry. As shown in Fig. 4d , the green uorescence intensity of P-TNPs increases from 67.1% to 96.2%, whereas almost no increase of the green uorescence intensity is observed in the no-treatment group (control group). The results indicate the 1 O 2 generation feasibility of P-TNPs at the intracellular level. The intracellular environment is different, aer all, from that in water solution.
Tissue penetration and bio-distribution
The tissue penetration depth of aerglow generated by P-TNPs was assessed using pork slabs of different thicknesses according to the published protocols. 1,66,67 200 mL of P-TNPs (0.1 mg mL À1 ) was placed in a 96-well plate along with PNPs with the same PFPV concentration which were used as a control. Aer irradiation for 2 min using a xenon lamp (2 W cm À2 ) xed 10 cm above the pork slab, the plate was transferred to an IVIS system to collect the aerglow signals. As shown in Fig. 5a , P-TNPs show much better tissue penetration ability than PNPs. To be specic, the aerglow luminescence of P-TNPs covered with a 5 mm-6 mm thick pork slab is still distinct while the aerglow signals of PNPs can hardly be observed even at the 1st signal collection, let alone at the 2nd time collection. As expected, the aerglow signals of P-TNPs can still be seen 4 min post ceasing irradiation thanks to the red AIE dye doping. This experiment further shows that the AIE dye TTMN powers PFPV to produce strong aerglow signals, red-shied emission and also prolonged aerglow time.
Before the in vivo tumour aerglow imaging study, the biodistribution of P-TNPs was investigated on 4T1 tumourbearing BALB/c nude mice. The uorescence images of tissues including the liver, heart, spleen, lung, kidney and tumour were captured in the IVIS system separately 6 h, 12 h and 24 h aer intravenous injection of P-TNP solution (Fig. 5b) . A bright region is found at the liver site 6 h aer injection due to the uptake of nanomaterials in the hepatic reticuloendothelial system. The uorescence intensity of the tumour reaches the highest level at 12 h post injection which might be ascribed to the enhanced permeability and retention effect (EPR), whereas the uorescence intensity of the liver gradually decreases because of its metabolic function. Quantitative analysis of the mean uorescence intensity (Fig. 5c ) in collected tissues reveals that the accumulation of P-TNPs in the tumour reaches the apex at 12 h post injection which is about 1.59-fold that at 6 h post injection, while the signal of the liver at 24 h reduces to $0.53fold that at 6 h post injection. The bio-distribution data suggest that P-TNPs can target the tumour and aer that undergo hepatic clearance from the body.
In vivo aerglow imaging on tumour-bearing mice
Aer verifying the cytocompatibility and bio-distribution of P-TNPs, the aerglow performance of P-TNPs was evaluated on tumour-bearing mice. 4T1 tumour-bearing nude mice were divided into three groups corresponding to three time points of 6 h, 12 h and 24 h post intravenous injection. The PNP (without AIE doping) group was used as a control to the P-TNP group. It can be seen from the uorescence modality that the uorescent signals are obvious at the tumour site (Fig. 6a) , and the signal intensities of the P-TNP group are 2.87-fold, 1.60-fold and 3.45fold, respectively, higher than those of the PNP group at three time points (Fig. 6b ) due to the FRET, resulting in the enhancement of TTMN red uorescence emission. Although the tumour sites can be visualized by uorescence imaging aer accumulation of P-TNPs or PNPs in tumour lesions, the tumour boundary is difficult to identify on account of the interference from the mouse body-induced autouorescence. Thus it can cause a phenomenon in which the uorescence intensity of P-TNPs at 24 h post injection is higher than that at 12 h post injection, which is different from that of PNPs.
In contrast, the aerglow imaging modality possesses much lower tissue background noise than the uorescence imaging modality. As shown in Fig. 6a , the aerglow signals are much easier to detect at the tumour site aer xenon lamp irradiation (2 W cm À2 , 2 min). The most intense signal appears at 12 h post intravenous injection, which is consistent with the results of the bio-distribution test. Moreover, the mean aerglow intensity of the tumour site in the P-TNP group is 2.75-fold, 2.89-fold and 2.67-fold, respectively, higher than that of the PNP group aer quantitative calculation (Fig. 6b ). We can see that both the uorescence and aerglow signals of P-TNPs at tumour sites are much higher than those of PNPs.
It is important to note that the aerglow of P-TNPs can be reexcited in vivo. As shown in Fig. 6c , the re-excited aerglow signals of P-TNPs are still strong enough to detect. These data suggest the superior performance of P-TNP mediated aerglow imaging over uorescence imaging, and the excellent reexcitable property of P-TNPs makes them more suitable for tumour diagnosis.
In vivo toxicology analysis
Blood routine analysis and serum biochemical analysis were carried out aer the intravenous injection of P-TNPs on the 1st, 7th and 14th day post injection. As shown in Fig. 7 , seven markers of blood routine including red blood cells (RBCs), hemoglobin (HGB), hematocrit (HCT), platelets (PLT), mean corpuscular hemoglobin (MCH), mean corpuscular volume (MCV) and mean corpuscular hemoglobin concentration (MCHC) in the P-TNP treated group remain within the normal ranges, and there is no signicant difference from those of the control group. For serum biochemical analysis, renal function markers (such as urea) and hepatic function markers including aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), alanine albumin (ALB) and total protein show no signicant difference between the treated group and the control group.
Hematoxylin and eosin (H&E) staining was further carried out to evaluate potential tissue lesion or inammation. The results presented in Fig. 8 reveal that liver cell edema occurs in the treated group on day 7, but recovers to the normal state on day 14 and no obvious abnormalities are found in other organs. These results suggest low toxicity of P-TNPs.
Conclusions
In summary, an AIE dye-powered organic aerglow luminogen (P-TNPs) is reported and it shows superior aerglow performance to the current SP-based aerglow materials and ACQ photosensitizer-amplied aerglow materials. The resultant P-TNPs possess much stronger aerglow emission and a prolonged aerglow time compared with those of PNPs. Particularly, the underlying aerglow mechanism especially the delayed generation of 1 O 2 is clearly demonstrated through various experiments, which is not achieved by the previous reports. We found that the delayed 1 O 2 promotes the self-excited aerglow effect and thus prolongs the aerglow time and intensity. Thanks to the improved aerglow properties, P-TNPs have shown good performance in in vivo tumour imaging. Overall, this work proposes an effective approach to improve the aerglow performance of SP materials and circumvent the issues of ACQ dye-doped aerglow materials. The disclosed mechanism we believe can inspire the development of other effective AIE-facilitated aerglow materials for tumour imaging and even therapy. 
Synthesis of TTMN
4-Bromotriphenylamine (0.97 g, 3 mmol), 4-formylthiophene-2boronic acid (0.70 g, 4.5 mmol) and anhydrous K 2 CO 3 (2.07 g, 15 mmol) were added to a mixture of toluene (15 mL) and methanol (15 mL), purged with nitrogen and stirred for 2 min, and then PdCl 2 (dppf) (0.07 g, 0.01 mmol) was added and purged with nitrogen for another two times. The whole mixture was stirred at 75 C for 12 h. Aer cooling down to room temperature, the mixture was evaporated, then dissolved in dichloromethane and washed with brine and water, subsequently dried with anhydrous Na 2 SO 4 , and further puried by silica-gel column chromatography using petroleum ether and ethyl acetate (from 40 : 1 to 10 : 1) to yield a yellow solid, 0.58 g. The obtained solid (150 mg, 0.42 mmol) and malononitrile (36.24 mg, 0.55 mmol) were added to ethanol (10 mL) and stirred at 78 C for 48 h. Aer cooling down to room temperature, the mixture was evaporated and puried by silica-gel column chromatography using petroleum ether and ethyl acetate (from 30 : 1 to 5 : 1) to yield a red solid, TTMN (140 mg, 82%).
Synthesis of P-TNPs
PFPV (1 mg), TTMN (from 0 to 200 mg) and F127 (20 mg) were dissolved in 1 mL of THF to form a clear solution, and then rapidly injected into DI water (9 mL) under sonication for 3 min with a sonicator (Scientz, JY92-2D). Aer that, the mixture was stirred in the dark for 12 h at room temperature to evaporate THF. The resulting solution was ltered with a syringe-lter (0.22 mm) and concentrated by ultraltration with DI water or PBS under centrifugation at 6000 rpm for 20 min. PFPV-Ce6 NPs were prepared by the same method, except that the addition amount of Ce6 was according to the molar mass of corresponding TTMN. All the prepared nanoparticles were stored in the dark at 4 C.
Characterization 1 H NMR spectra of TTMN were recorded on a Bruker Avarice TM NMR spectrometer, and the corresponding purity and molecular weight were measured using an LC-MS (Waters, UPLC H-CLASS-SQD). An FEI Tecnai G2 F20 instrument was used to obtain TEM images at a voltage of 200 kV. Hydrodynamic size distribution and z-potential were measured by DLS (Malvern Zetasizer Nano ZS). The UV-vis absorption spectra and uorescence spectra were, respectively, recorded on Cary 60 (Agilent) and Cary Eclipse (Agilent) instruments. Biological uorescence images were collected on a uorescence microscope (OLYMPUS, IX73). Aerglow images and in vivo uorescence images were obtained by using an IVIS spectrum imaging system (Berthold, NightOWL LB 983).
Aerglow luminescence measurement
Aerglow signals were collected using an IVIS spectrum imaging system (6 Â 6 binning, exposure time 60 s) under bioluminescence mode. Typically, 200 mL of P-TNPs (0.1 mg mL À1 , based on the concentration of PFPV) was placed in Eppendorf (EP) tubes or 96-well plates, and then preilluminated using a white LED lamp (2000 lm) for 1 min in a xed position. The aerglow images were acquired with an open lter (full-wave reception) or a 630 nm emission lter and the decay of the aerglow was collected by continuous operation of the imaging soware without any movement of the samples. The data of aerglow images were analyzed by using the IndiGo soware.
In vitro evaluation of 1 O 2 generation
The 1 O 2 generation of H 2 O, PNPs, TNPs and P-TNPs was evaluated using ABDA and SOSG as indicators, respectively. In brief, 40 mL of ABDA (1 mM) was added to 2 mL of PFPV-TTMN NP solution, and the original absorption spectrum was recorded. The mixture was irradiated with a white LED lamp (2000 lm) every 2 min and the absorption spectra were measured at every interval. For comparison, the concentrations of PNPs and TNPs were prepared the same as P-TNPs (PFPV 0.1 mg mL À1 , TTMN 0.01 mg mL À1 ). The absorption of ABDA at 375 nm was normalized to calculate the decomposition rate of ABDA. For another indicator, SOSG, the measurement was conducted in a similar way. 100 mL of SOSG (50 mM) was added to 2 mL of P-TNP solution, and irradiated as the previous method. Then, the uorescence intensity of SOSG (excitation at 504 nm, emission at 525 nm) was normalized to calculate the increase rate. Another way is to only set the addition time of SOSG aer the irradiation. To demonstrate the 1 O 2 generation in another way, a classic 1 O 2 quencher DABCO was employed. One method is to add 20 mL of DABCO (2.5 M) or H 2 O to PNPs and P-TNPs (180 mL) in 96-well plates, respectively. The prepared samples were irradiated with a white LED lamp (2000 lm) for 1 min, and then the aerglow signals were collected using an IVIS spectrum imaging system as before. The other method is to only set the addition time of DABCO aer the irradiation.
Cell experiments
The 4T1 murine breast cancer cells and the DC2.4 dendritic cells were employed to evaluate the cytotoxicity of P-TNPs. 4T1 cells were cultured in DMEM and DC2.4 were cultured in RMPI 1640 at 37 C under a humidied 5% CO 2 atmosphere, both containing 10% fetal bovine serum and 1% penicillin-streptomycin. For cytotoxicity experiments, 4T1 cells and DC2.4 cells were seeded in 96-well plates at a density of 1 Â 10 4 cells per well and cultured for 24 h to allow cell adherence. The medium was then replaced by 200 mL of fresh medium containing P-TNPs at various concentrations (0-500 mg mL À1 , based on freeze-dried weight) for another 24 h and 48 h of incubation. The medium in each well was replaced by fresh medium with the CCK-8 agent and further incubated for 4 h. Finally, the absorption at 450 nm was recorded on a microplate reader (Thermo, Mutilskan MK3). Due to the absorption of P-TNPs at 440 nm, the absorption of the medium containing each concentration of P-TNPs was also recorded.
To evaluate the intracellular 1 O 2 generation of P-TNPs, DCFH-DA was employed as an indicator. 4T1 cells were seeded in a 35 mm cell well with a density of 4 Â 10 5 cells per well and cultured for 24 h to allow cell adherence. The medium was then replaced by 1 mL of fresh medium containing DCFH-DA (10 mM) for 0.5 h of incubation. Then, the cells were washed with DMEM without fetal bovine serum at least three times and incubated with 1 mL of fresh medium containing P-TNPs (200 mg mL À1 , based on freeze-dried weight) for 2 h. Aer that, the cells were washed with PBS three times and irradiated using a white LED lamp (2000 lm) for 3 min. Finally, the cells were observed using a uorescence microscope and analyzed by ow cytometry (Invitrogen/A24684).
In vitro tissue-penetration study
Typically, 200 mL of PNPs and P-TNPs (PFPV concentration, 0.1 mg mL À1 ) were placed in a 96-well plate and covered with pork slabs of different thicknesses. Subsequently, the covered samples were irradiated using a xenon lamp (BETICAL, HDL-II, 2 W cm À2 ) for 2 min. The aerglow images were acquired for 60 s with an open lter and $630 nm lter, respectively.
Animal model and in vivo imaging
All animal procedures were performed in accordance with the Guidelines for Care and Use of Laboratory Animals published in GB/T 35892-2018 and the experiments were approved by the Animal Ethics Committee of Tongji University. For tumour model establishment, 4T1 cells (1-2 Â 10 6 cells per mouse) suspended in 100 mL PBS were subcutaneously injected into the right thigh of female BLAB/c nude mice (6 weeks old, body weight ca. 20 g). For the tissue bio-distribution study, the mice were sacri-ced at the 6 h, 12 h and 24 h time points aer the intravenous injection of P-TNPs (200 mL, 1 mg mL À1 based on PFPV concentration). Major organs including the liver, heart, spleen, lung, kidney and tumour were collected and washed with PBS quickly. The uorescence images of organs were acquired for 0.1 s at 630 nm with the excitation at 475 nm. The uorescence intensity of each organ was analyzed by using the IndiGo soware.
For tumour aerglow imaging, all mice were divided into three groups and anesthetized at the 6 h, 12 h and 24 h time points aer the intravenous injection of P-TNPs (0.2 mL, 0.1 mg mL À1 based on PFPV concentration). The uorescence images of the mice were acquired for 0.1 s at 630 nm with the excitation at 475 nm. Before capturing aerglow images, the mice were, respectively, irradiated for 2 min with a xenon lamp (2 W cm À2 ) xed 10 cm above the tumour sites. The aerglow images were acquired for 60 s (6 Â 6 binning) with an open lter and the decay images of aerglow were captured right aer the rst acquisition. The second round aerglow images were also obtained by reirradiating the mice aer the acquisition of aerglow decay images under the same conditions. The uorescence and aerglow intensity were analyzed by using the IndiGo soware.
Blood biochemical analysis and histopathological examination
Healthy female BLAB/c mice were divided into four groups (n ¼ 3) and intravenously injected with a dose the same as that of in vivo imaging, except the control group (mice without any treatment). The blood samples were collected for blood chemistry analysis and routine blood analysis at the 1st day, 7th day and 14th day. The blood samples of the control group were also collected and analyzed on the 1st day. Major organs including the liver, heart, spleen, lung and kidney were collected and xed with 4% paraformaldehyde, then embedded in paraffin, sliced and stained using H&E. Finally, the images of all samples were obtained by using an optical microscope (OLYMPUS, IX73).
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